Winton Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-8,400
Closed -$210K – 1550
2026
Q1
$210K Sell
8,400
-2,780
-25% -$65.8K 0.01% 969
2025
Q4
$294K Buy
+11,180
New +$244K 0.01% 747
2024
Q2
– Sell
-91,685
Closed -$965K – 766
2024
Q1
$965K Buy
91,685
+41,700
+83% +$463K 0.07% 285
2023
Q4
$519K Sell
49,985
-10,305
-17% -$82.1K 0.04% 290
2023
Q3
$382K Buy
60,290
+17,084
+40% +$126K 0.03% 408
2023
Q2
$373K Buy
+43,206
New +$387K 0.03% 440
2021
Q4
– Sell
-17,977
Closed -$522K – 1455
2021
Q3
$522K Sell
17,977
-6,239
-26% -$207K 0.03% 838
2021
Q2
$840K Buy
24,216
+2,281
+10% +$72.4K 0.05% 629
2021
Q1
$693K Buy
21,935
+7,509
+52% +$305K 0.04% 692
2020
Q4
$682K Buy
+14,426
New +$670K 0.05% 622

Other funds holding ZYME

Winton Group's ZYME Position: Q2 2026 in Review

Winton Group sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 8,400 shares — an estimated $210K sold.

Winton Group first reported a position in ZYME in Q4 2020 and held it in 10 quarters. The position peaked at $965K in Q1 2024. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Winton Group reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 8,400 Zymeworks shares in Q2 2026, an estimated $210K.
  • Winton Group first reported a position in Zymeworks in Q4 2020 and held it in 10 quarters.
  • Winton Group's Zymeworks position peaked at $965K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.